Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

(2018) James McKiernan et al.   EUROPEAN UROLOGY

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting

(2017) Jay White et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

(2016) James McKiernan et al.   JAMA Oncology

Improving Prostate Cancer Screening and Diagnosis

(2016) Hiten D. Patel et al.   JAMA Oncology

PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer

(2015) A. El-Shater Bosaily et al.   Contemporary Clinical Trials

The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort

(2014) Alexis R. Gaines et al.   CANCER CAUSES & CONTROL

Increasing Risk of Infectious Complications After Transrectal Ultrasound–Guided Prostate Biopsies: Time to Reassess Antimicrobial Prophylaxis?

(2012) Alex Carignan et al.   EUROPEAN UROLOGY

Trends in PSA, age and prostate cancer detection among black and white men from 1990-2006 at a tertiary care center

(2010) Jeannette M. Potts et al.   CANCER

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute